Rothschild Investment LLC Sells 1,098 Shares of Baxter International Inc. (NYSE:BAX)

Rothschild Investment LLC cut its holdings in Baxter International Inc. (NYSE:BAX) by 7.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 13,998 shares of the medical instruments supplier’s stock after selling 1,098 shares during the period. Rothschild Investment LLC’s holdings in Baxter International were worth $408,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of the business. Fortitude Family Office LLC bought a new position in Baxter International in the 3rd quarter valued at $38,000. LRI Investments LLC grew its position in Baxter International by 60.8% during the third quarter. LRI Investments LLC now owns 1,560 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 590 shares during the period. Bruce G. Allen Investments LLC grew its position in shares of Baxter International by 247.3% during the 4th quarter. Bruce G. Allen Investments LLC now owns 2,622 shares of the medical instruments supplier’s stock valued at $76,000 after acquiring an additional 1,867 shares during the period. CKW Financial Group grew its position in shares of Baxter International by 19.3% during the 4th quarter. CKW Financial Group now owns 2,625 shares of the medical instruments supplier’s stock valued at $77,000 after acquiring an additional 425 shares during the period. Finally, Farther Finance Advisors LLC grew its position in shares of Baxter International by 23.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,519 shares of the medical instruments supplier’s stock valued at $96,000 after acquiring an additional 475 shares during the period. 90.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on BAX shares. Stifel Nicolaus reduced their price objective on Baxter International from $46.00 to $38.00 and set a “buy” rating for the company in a report on Monday, November 11th. Argus upgraded Baxter International from a “hold” rating to a “buy” rating in a research note on Monday. Barclays initiated coverage on Baxter International in a research note on Thursday, February 20th. They set an “overweight” rating and a $39.00 price target for the company. StockNews.com lowered shares of Baxter International from a “buy” rating to a “hold” rating in a research report on Monday, November 11th. Finally, JPMorgan Chase & Co. cut their target price on shares of Baxter International from $38.00 to $36.00 and set a “neutral” rating for the company in a research report on Friday, February 21st. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat, Baxter International currently has a consensus rating of “Hold” and a consensus target price of $38.80.

Baxter International Stock Up 2.6 %

Shares of NYSE:BAX opened at $36.00 on Wednesday. The firm has a fifty day moving average price of $30.89 and a two-hundred day moving average price of $34.07. The company has a market cap of $18.38 billion, a price-to-earnings ratio of -28.13, a PEG ratio of 0.93 and a beta of 0.61. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.43 and a quick ratio of 1.09. Baxter International Inc. has a one year low of $28.33 and a one year high of $44.01.

Baxter International (NYSE:BAX) last posted its quarterly earnings data on Thursday, February 20th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.06. The company had revenue of $2.75 billion during the quarter, compared to analyst estimates of $2.67 billion. Baxter International had a positive return on equity of 16.67% and a negative net margin of 5.05%. Analysts anticipate that Baxter International Inc. will post 2.48 EPS for the current fiscal year.

Baxter International Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Friday, February 28th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.89%. The ex-dividend date is Friday, February 28th. Baxter International’s dividend payout ratio is currently -53.13%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.